Allergy & Immunology CE Activities

Case Challenges in Hereditary Angioedema: Innovative Therapeutic Strategies for a Normal Life: A Care Team Forum®

1.5 CE Credit(s)

New Horizons in Food Allergy: Best Practices & Treatment Advances for Unmet Needs: A Clinical Transfers®

1.0 CE Credit(s)

A Non-CME Educational Program during the 2025 AAAAI/WAO Joint Congress: Expert Panel Discussion Featuring a Patient

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

1.0 CE Credit(s)

Challenging Cases in Asthma: Improving Quality of Life (3 of 3)

0.25 CE Credit(s)

Challenging Cases in Asthma: Optimizing Biologics in Adults (2 of 3)

0.25 CE Credit(s)

ALLERGY & iMMUNOLOGY blog

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.

Allergy & Immunology, Pulmonology
Blog

Try These Diets for Your Patients with EoE

In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.

Allergy & Immunology
Blog

RMEI Presentations

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we’ve learned so far

LATEST ALLERGY & IMMUNOLOGY ARTICLES

Latest Allergy & Immunology Articles

Generalized Pustular Psoriasis June 19, 2025
A 54-year-old woman with well-controlled chronic plaque psoriasis presented with a 2-day history of painful rash and fever. Widespread erythematous patches with overlying, coalescing pustules were seen on examination.
Su-Chi Ku, Ying-Yi Chiang
Myasthenia Gravis — Redemption for B-Cell Depletion June 19, 2025
Myasthenia gravis, an immune-mediated neurologic disorder, has for the past century been treated effectively with various immunotherapies, ranging from thymectomy to approved targeted agents.1,2 The neuromuscular transmission defect of myasthenia gravis is driven by autoreactive immunoglobulins directed postsynaptically. Hence, it is no large leap to posit that therapies...
Gil I. Wolfe, Shahar Shelly
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis June 19, 2025
In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and reduced disease severity at 26 weeks.
Richard J. Nowak, Michael Benatar, Emma Ciafaloni, James F. Howard Jr., M. Isabel Leite, Kimiaki Utsugisawa, John Vissing, Mikhail Rojavin, Qing Li, Fengming Tang, Yanping Wu, Nishi Rampal, Sue Cheng, the MINT Investigators*

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021